LV Management Group, LLC, 10% Owner at Protagonist Therapeutics, Inc (PTGX), bought 583,333 shares at $12.00 ($7.0M) on 2016-08-16, disclosed to the SEC on 2016-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.